Shire and TAP Agree to Co-promote LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild t
BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire/ --
- Forms One of the Largest Sales Teams Promoting a 5-ASA Medicine
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty…